Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.
Hayashi
R
R
Hayakawa
N
N
Makino
M
M
Nagata
M
M
Kakizawa
H
H
Uchimura
K
K
Hamada
M
M
Aono
T
T
Fujita
T
T
Shinohara
R
R
Nagasaka
A
A
Itoh
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000449:Aldehyde Reductase / Q000627:therapeutic use; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000097:blood*; D003929:Diabetic Neuropathies / Q000097:blood*; D003930:Diabetic Retinopathy / Q000097:blood*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D015203:Reproducibility of Results; D012236:Rhodanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013012:Sorbitol / Q000097:blood*; D013053:Spectrophotometry / Q000379:methods; D053778:Thiazolidines
D000449:Aldehyde Reductase; D001786:Blood Glucose; D004791:Enzyme Inhibitors; D006442:Glycated Hemoglobin; D012236:Rhodanine; D013012:Sorbitol; D053778:Thiazolidines; C038131:epalrestat